U.S. markets closed

Edwards Lifesciences Corporation (EW)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
80.41+1.03 (+1.30%)
At close: 4:00PM EDT
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Annual
Quarterly
Premium required to access monthly data
Monthly
Subscribe to Premium to download historical data
 
As of Date: 10/23/2020
Current
9/30/20206/30/20203/31/202012/31/20199/30/2019
Market Cap (intraday) 5
49.35B49.63B42.94B38.95B48.78B45.85B
Enterprise Value 3
48.75B49.15B42.59B38.11B48.09B45.59B
Trailing P/E
63.0068.0339.7238.2663.9264.30
Forward P/E 1
35.8436.1041.4932.4737.4536.23
PEG Ratio (5 yr expected) 1
2.812.823.201.952.062.01
Price/Sales (ttm)
11.4611.689.819.2111.9211.78
Price/Book (mrq)
11.7212.9311.019.3912.7913.10
Enterprise Value/Revenue 3
11.1643.0846.0433.7740.9641.67
Enterprise Value/EBITDA 6
38.98137.59167.4897.00150.67141.13

Trading Information

Stock Price History

Beta (5Y Monthly) 0.90
52-Week Change 31.75%
S&P500 52-Week Change 314.01%
52 Week High 387.79
52 Week Low 351.51
50-Day Moving Average 381.55
200-Day Moving Average 375.96

Share Statistics

Avg Vol (3 month) 32.36M
Avg Vol (10 day) 32.55M
Shares Outstanding 5621.74M
Float 617.14M
% Held by Insiders 10.67%
% Held by Institutions 189.06%
Shares Short (Sep 29, 2020) 46.69M
Short Ratio (Sep 29, 2020) 42.32
Short % of Float (Sep 29, 2020) 41.09%
Short % of Shares Outstanding (Sep 29, 2020) 41.08%
Shares Short (prior month Aug 30, 2020) 47.24M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 23:1
Last Split Date 3May 31, 2020

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Sep 29, 2020

Profitability

Profit Margin 18.18%
Operating Margin (ttm)29.85%

Management Effectiveness

Return on Assets (ttm)12.77%
Return on Equity (ttm)19.79%

Income Statement

Revenue (ttm)4.37B
Revenue Per Share (ttm)7.01
Quarterly Revenue Growth (yoy)4.30%
Gross Profit (ttm)3.23B
EBITDA 1.4B
Net Income Avi to Common (ttm)794.1M
Diluted EPS (ttm)1.26
Quarterly Earnings Growth (yoy)18.40%

Balance Sheet

Total Cash (mrq)1.3B
Total Cash Per Share (mrq)2.08
Total Debt (mrq)690.1M
Total Debt/Equity (mrq)16.39
Current Ratio (mrq)3.52
Book Value Per Share (mrq)6.77

Cash Flow Statement

Operating Cash Flow (ttm)N/A
Levered Free Cash Flow (ttm)N/A